Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Myricx, headquartered in London, is a biotech company dedicated to discovering and developing a groundbreaking class of payloads for antibody-drug conjugates (ADCs). Our focus is on leveraging inhibitors of N-myristoyltransferases (NMT) to create innovative treatments for cancer.

List your booth number for exhibitions, ask us